BR112015016548A2 - polimixinas , composições , métodos de preparação e métodos de uso - Google Patents

polimixinas , composições , métodos de preparação e métodos de uso

Info

Publication number
BR112015016548A2
BR112015016548A2 BR112015016548A BR112015016548A BR112015016548A2 BR 112015016548 A2 BR112015016548 A2 BR 112015016548A2 BR 112015016548 A BR112015016548 A BR 112015016548A BR 112015016548 A BR112015016548 A BR 112015016548A BR 112015016548 A2 BR112015016548 A2 BR 112015016548A2
Authority
BR
Brazil
Prior art keywords
methods
polymyxins
compositions
preparation
preparation methods
Prior art date
Application number
BR112015016548A
Other languages
English (en)
Inventor
Melander Claes
Mansson Martin
Gunnes Solvi
Koch Torben
Bjornstad Vidar
Original Assignee
Xellia Pharmaceuticals Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps
Publication of BR112015016548A2 publication Critical patent/BR112015016548A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
BR112015016548A 2013-01-11 2014-01-09 polimixinas , composições , métodos de preparação e métodos de uso BR112015016548A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751341P 2013-01-11 2013-01-11
US201361904793P 2013-11-15 2013-11-15
PCT/EP2014/050320 WO2014108469A1 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Publications (1)

Publication Number Publication Date
BR112015016548A2 true BR112015016548A2 (pt) 2017-07-11

Family

ID=50101865

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015016548A BR112015016548A2 (pt) 2013-01-11 2014-01-09 polimixinas , composições , métodos de preparação e métodos de uso

Country Status (20)

Country Link
US (1) US10640536B2 (pt)
EP (1) EP2943503B1 (pt)
JP (1) JP6316846B2 (pt)
KR (1) KR20150107793A (pt)
CN (1) CN104918951B (pt)
AU (1) AU2014204873B2 (pt)
BR (1) BR112015016548A2 (pt)
CA (1) CA2895910C (pt)
EA (1) EA027067B1 (pt)
ES (1) ES2641017T3 (pt)
HU (1) HUE034562T2 (pt)
IL (1) IL239840A (pt)
MX (1) MX360905B (pt)
PT (1) PT2943503T (pt)
RU (1) RU2015132569A (pt)
SI (1) SI2943503T1 (pt)
TW (1) TWI613219B (pt)
UA (1) UA117673C2 (pt)
WO (1) WO2014108469A1 (pt)
ZA (1) ZA201504565B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10640536B2 (en) 2013-01-11 2020-05-05 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
TW201522364A (zh) * 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
SI3166960T1 (sl) 2014-07-09 2019-12-31 Xellia Pharmaceuticals Aps Nizko substituirani polimiksini v njihovi sestavki
LT3200762T (lt) 2014-10-03 2019-06-10 Xellia Pharmaceuticals Aps Inhaliacinis įrenginys
MX2017004176A (es) * 2014-10-03 2017-08-28 Xellia Pharmaceuticals Aps Composicion.
KR102585108B1 (ko) 2014-12-16 2023-10-05 상하이 미큐알엑스 파마슈티컬 컴퍼니 리미티드 세균 감염의 치료를 위한 항미생물성 폴리믹신
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
AU2016331658B2 (en) * 2015-09-29 2021-04-01 Monash University Antimicrobial polymyxin derivative compounds
CN109996806B (zh) * 2016-12-09 2021-11-02 正大天晴药业集团股份有限公司 高效价的多黏菌素e2甲磺酸钠
US20230141981A1 (en) 2020-01-21 2023-05-11 Shanghai Micurx Pharmaceuticals Co., Ltd Novel compounds and composition for targeted therapy of kidney-associated cancers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
FR1586834A (pt) 1968-02-12 1970-03-06
JPH02504003A (ja) * 1988-04-07 1990-11-22 シャンブロム,エドワード 非トロンボゲン形成性脈管内タイムリリースカテーテル
AU730546B2 (en) 1996-11-15 2001-03-08 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
DE60210402T2 (de) 2001-05-18 2006-12-07 Chiron Corp., Emeryville System zur Abgabe einer Tobramycin-Formulierung
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
EP1940859A1 (en) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
US10640536B2 (en) 2013-01-11 2020-05-05 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
SI3166960T1 (sl) 2014-07-09 2019-12-31 Xellia Pharmaceuticals Aps Nizko substituirani polimiksini v njihovi sestavki
MX2017004176A (es) 2014-10-03 2017-08-28 Xellia Pharmaceuticals Aps Composicion.

Also Published As

Publication number Publication date
KR20150107793A (ko) 2015-09-23
CA2895910A1 (en) 2014-07-17
ES2641017T3 (es) 2017-11-07
EA027067B1 (ru) 2017-06-30
CN104918951B (zh) 2018-03-30
EP2943503A1 (en) 2015-11-18
US10640536B2 (en) 2020-05-05
TWI613219B (zh) 2018-02-01
WO2014108469A1 (en) 2014-07-17
IL239840A (en) 2017-09-28
MX2015008878A (es) 2015-10-30
TW201429995A (zh) 2014-08-01
EP2943503B1 (en) 2017-08-23
CN104918951A (zh) 2015-09-16
UA117673C2 (uk) 2018-09-10
JP2016505007A (ja) 2016-02-18
IL239840A0 (en) 2015-08-31
EA201591280A1 (ru) 2015-12-30
SI2943503T1 (sl) 2017-11-30
CA2895910C (en) 2021-12-21
HUE034562T2 (en) 2018-03-28
JP6316846B2 (ja) 2018-04-25
RU2015132569A (ru) 2017-02-14
US20160002296A1 (en) 2016-01-07
AU2014204873B2 (en) 2017-07-06
ZA201504565B (en) 2016-11-30
MX360905B (es) 2018-11-21
PT2943503T (pt) 2017-09-28
AU2014204873A1 (en) 2015-07-09

Similar Documents

Publication Publication Date Title
BR112016030968A2 (pt) análogos de pridopidina, preparação e uso destes
CL2015003440A1 (es) Composiciones de arni contra tmprss6 y métodos para su uso
BR112016003454A2 (pt) Uso de composto de metil bardoxolona
IL265876A (en) Preparations that include 15-ohepa and methods of using them
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
HUE048666T2 (hu) Mezõgazdasági endofita-növény kompozíciók és alkalmazási eljárások
EP3068517A4 (en) Compositions of lean nox trap
HK1214171A1 (zh) 賽尼克韋羅組合物及其製備和使用方法
BR112015016548A2 (pt) polimixinas , composições , métodos de preparação e métodos de uso
EP2961382A4 (en) TOPICAL COMPOSITIONS AND METHODS OF USE
EP2964235A4 (en) ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE
BR112016006614A2 (pt) composições de trichoderma e métodos de uso
BR112016004003A2 (pt) Composto de tetrazolinona e uso do mesmo
CL2015002110A1 (es) Parvovirus porcino 5b, métodos de uso y vacuna
SG11201510266SA (en) Dengue virus vaccine compositions and methods of use thereof
CL2016000998A1 (es) Composición herbaria, procedimiento para su preparación y uso de la misma
SMT201700004B (it) Uso di estratti di salvia haenkei in composizioni per antisenescenza
BR112015002938A2 (pt) compostos de carboxamida pirazol, composições e métodos de uso
FR3007291B1 (fr) Composition cicatrisante et utlisation
HK1217670A1 (zh) 調配物、其製造方法和用途
BR112016008035A2 (pt) composição, uso da composição
FI20136136A (fi) Menetelmä kosmeettisten koostumusten valmistamiseksi, kosmeettiset koostumukset sekä niiden käyttö
CL2015001116A1 (es) Composición y uso de dimeros de alquil cetena hidrogenados.
BR112015017670A2 (pt) composição agroquímica e método de uso da mesma
BR112015030989A2 (pt) composição farmacêutica, e, uso de uma composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements